How a Yorkshire house led to five pioneering research projects
Last year you raised an incredible £1.95m for Blood Cancer UK in the Omaze Millon Pound House Draw.
This has allowed us to launch our new Omaze X Blood Cancer UK research fund which is helping to support research into new and better treatments for blood cancer.
Thanks to you, this has allowed us to fund six amazing new research projects.
Project 1: Giving people with EBV-positive cancers a better chance of survival
Professor Michelle West is researching a less harmful way to treat blood cancers caused by the Epstein-Barr virus (EBV).
Read more about about how this research project is helping to create a new, less to toxic drug treatment for people with blood cancer.
Project 2: A less harmful treatment for AML
Professor Georges Lacaud is looking to understand more about a specific protein and how it could be used as a kinder treatment for acute myeloid leukaemia (AML).
Read more about this research project and how it is unlocking a treatment with fewer side effects than current treatment options.
Project 3: Treating a rare type of blood cancer
Dr Kiran Batta, plans to investigate the role of a specific gene in a rare type of blood cancer called chronic myelomonocytic leukaemia (CMML), to help scientists to find a new way to treat the disease.
Read more about how this gene could help scientists to find new ways to treat CMML.
Project 4: A new avenue for CAR-T Therapy
Dr Sara Ghorashian is using CAR-T therapy to develop a safer and more effective way to treat children with myelodysplastic syndrome (MDS) who are at risk of their cancer developing into acute myeloid leukaemia (AML).
Read more about how this research could lead to a new and more effective treatment for children with MDS.
Project 5: A new drug treatment for mastocytosis
Professor Claus Nerlov is working towards developing a new drug that can effectively target and treat a blood disorder called mastocytosis.
Read more about how this research will help in the development of a new effective treatment for people with mastocytosis.
Project 6: Treating myeloma with immune system enhancing drugs
Dr Sarah Dimeloe is testing drugs used to treat other diseases to see if these can help the body’s immune cells to destroy cancerous myeloma cells.
Read more about how this research could allow drugs to be repurposed and used as a kinder way to treat myeloma.
Watch: Simon Thomas announces the Omaze x Blood Cancer UK fund
Find out more